Neonatal and Prenatal Devices Market Size & Share - Growth Analysis and Forecast 2026-2035

Neonatal and Prenatal Devices Market - Regional Analysis

North America Market Insights

North America neonatal and prenatal devices market is anticipated to garner the highest share of 38.6% during the forecast period. The region’s leadership is mainly attributable to its highly advanced healthcare infrastructure, including a dense network of tertiary care hospitals, well-established NICUs, and enhanced access to screening and monitoring technologies. The existence of this strong clinical ecosystem supports early diagnosis and effective management of high-risk pregnancies and neonatal complications. In August 2024, the U.S. FDA reported that its pediatric and perinatal devices program conducts regulatory science research to make sure safe and effective medical devices for children and mothers during pregnancy and childbirth. This program develops certain testing methods, datasets, and computational models to close gaps such as limited device availability, lack of suitable designs, and high development costs, thereby ultimately supporting innovation and access in pediatric and maternal care.

The expanding clinical infrastructure, high rates of NICU admissions, and consistent demand are uplifting the U.S. neonatal and prenatal devices market. Market growth is primarily driven by government support and the rapid clinical integration of advanced technologies that offer automated thermoregulation. In May 2026, the U.S. Department of Health and Human Services announced the launch of Moms.gov as a first-of-its-kind platform to support new and expecting mothers. The site provides resources on pregnancy centers, Federally Qualified Health Centers, nutrition, mental health, breastfeeding, adoption, and more, also introducing tools such as Trump Accounts and Trump Rx. thus, strengthening maternal and infant health outcomes. With such support, the country is anticipated to witness exceptional growth in the next decade.

In Canada, the neonatal and prenatal devices market has gained immense exposure, mainly propelled by the country’s robust public healthcare framework and a strong institutional commitment to minimizing infant mortality rates. Market expansion is also driven by the modernization of provincial hospital networks and the integration of digital health infrastructure, which deliberately facilitates the adoption of wireless fetal telemetry and smart connected incubators. Based on the government data published in January 2026, the Community Action for Prenatal and Child Health Program funds nearly 495 projects on a yearly basis, thereby serving more than 230,000 pregnant people, young children aged 0 to 6, and caregivers across Canada. It unifies the Canada Prenatal Nutrition Program and the Community Action Program for Children by focusing on families facing poverty, isolation, systemic barriers, or challenges such as teen pregnancy and substance use.

APAC Market Insights

The Asia Pacific market is projected to grow at the fastest rate from 2026 to 2035. The region’s upliftment is mainly propelled by surging investments in healthcare infrastructure across both public and private sectors. Market growth is also being driven by rising disposable incomes, expanding medical insurance coverage, and proactive government health mandates, which are targeting early newborn screening. Based on the government data published in February 2026, a perinatal telemedicine project refined in Thailand and later adopted in Japan is saving lives by enabling real-time fetal monitoring at home through the iCTG device. This particular system uses two heart-shaped sensors to track fetal heartbeat and uterine contractions, transmitting data directly to hospitals for physician review, thus denoting a positive market outlook.

Government support with suitable subsidy programs and a focus on optimizing maternal and infant health outcomes are driving the growth of the neonatal and prenatal devices market in China. There is a rising trend in pregnancies among older demographics, which increases the clinical demand for advanced prenatal screening and continuous fetal monitoring systems. The country’s market is also benefiting from a strong domestic shift toward localized manufacturing of high-tech medical equipment, which accelerates the nationwide adoption of digital incubators and smart phototherapy devices. Based on the government data published in December 2025, China has announced plans to make childbirth essentially free under national medical insurance to reduce family financial burdens and foster a birth-friendly society. Seven provinces, including Shandong, already offer full coverage for standard hospital deliveries, with typical out-of-pocket costs dropping to USD 141.53 below, thus driving extensive usage of neonatal and prenatal devices.

Rising maternal age in urban areas and nationwide initiatives to reduce the neonatal mortality rate are accelerating the growth of the market in India. Market expansion is propelled by public healthcare programs along with a booming private healthcare sector expanding its premium neonatal intensive care unit footprints.  As stated by Press Information Bureau (PIB) in May 2026, the country’s Union Health Ministry launched JANANI (Journey of Antenatal, Natal and Neonatal Integrated Care), which is a digital platform to strengthen maternal and child healthcare in India. The platform’s key features include QR-enabled MCH cards, automated alerts for high-risk pregnancies, and interoperability with platforms such as U-WIN and POSHAN. Hence, such instances drive demand for neonatal and prenatal devices by enabling integration, monitoring, and data-driven adoption.

India Ultrasound Machine Shipments by Country in 2023: Leading Suppliers, Import Value, and Trade Analysis

Source: WITS

Europe Market Insights

The Europe market is progressing steadily owing to the presence of favorable universal reimbursement frameworks and clinical adoption of digital healthcare solutions. The region benefits from strict guidelines that mandate universal newborn screening for metabolic and congenital disorders, thereby ensuring consistent procurement of diagnostic devices across both public hospitals and private maternity clinics. In November 2023, at RSNA 2023, Philips introduced a suite of AI-enabled innovations that are especially designed to ease radiology workflows and improve patient care. Some of the highlights included next-generation ultrasound systems that boost diagnostic confidence, the world’s first mobile MRI with helium-free operations, and cloud-based PACS solutions integrating over 100 AI applications. Hence, such instances denote the industry’s shift towards integrated diagnostic ecosystems that improve workflow and maternal–fetal outcomes across healthcare systems.

A highly structured clinical guidelines and statutory health insurance framework that guarantees universal access to maternal-fetal care are fueling growth in the Germany neonatal and prenatal devices market. The country’s technological transition is being accelerated by substantial federal investments in hospital digitalization and the presence of prominent domestic medical engineering firms that prioritize the deployment of interconnected intensive care solutions. In May 2023, Siemens Healthineers announced a generous investment of USD 86 million to build a new semiconductor crystal factory in Forchheim, Germany, to expand capacity for photon-counting CT scanners such as the Naeotom Alpha. These cadmium telluride crystals enable sharper imaging with reduced radiation dose, addressing rising demand, thus contributing to the industry’s growth.

The UK neonatal and prenatal devices market has a strong opportunity to grow in the next decade, owing to the National Health Service (NHS) framework's strong focus on modernizing maternity services. Market growth is largely fueled by targeted government funding initiatives aimed at upgrading obstetric and pediatric units, which accelerate the procurement of next-generation fetal monitors, smart incubators, and advanced neonatal ventilators. Based on the government data published in April 2023, NHS England’s three-year delivery plan for maternity and neonatal services from 2023–2026 focuses on making care safer, more personalized, and equitable for women, babies, and families. In addition, its implementation relies on the dedication of maternity and neonatal teams across England, with a collective goal to improve outcomes and ensure consistent, high-quality care.